Prof. Emanuele Montomoli,

University of Siena, Italy, Dept of Public Health, Molecular Epidemiology Laboratory.

Via Aldo Moro 3, 53100 Siena, Italy. Tel: +39 0577 234134; Fax: +39 0577 234090

E-mail:

Biography

Emanuele Montomoli graduated in 1988 as an “Industrial Chemical Technician” at the Italian Technical Lyceum in Siena. In 1997 he graduated with a degree in Biology at the Physical, Mathematical and Natural Science Faculty of the University of Siena. In 2002 he completed his Biochemistry and Enzymology Specialization training at the University of Siena.

On July 2nd 2002 he won a competition in the Comparative Evaluation Procedure for a posting as University Professor at the Science Faculty of the University of Turin, in the “General and Applied Hygiene” area. On October 28th 2002 he was appointed Professor of Public Health by the Faculty of Medicine and Surgery of the University of Siena.

He has extensive experience in respiratory viruses, particularly influenza. Since 1994 he has been carrying out seroepidemiological research for evaluating the immune status of the population toward influenza viruses. Since 1995 he has mostly overseen clinical trials of vaccines, evaluating their immunogenicity and reactogenicity. His recent research is focused on the molecular epidemiology of respiratory viruses, particularly the influenza and avian influenza strains. Currently, his research interests are focused on the standardization of serological assays for vaccine immune response evaluation. He is the author of approximately thirty articles, as well as numerous abstracts and letters, published in Italian and international scientific journals.

Papers in International IF Journal.

  1. Cellesi C., Sansoni A., Casini S., Migliorini L., Zacchini F., Gasparini R., Montomoli E., Bonacci A., Bravi A.. Chlamydia pneumoniae and angiographically demonstred coronary artery disease in sample population from Italy.Atherosclerosis 1999 Jul; 145 (1): 81-5. IF: 2.88
  2. Bonanni P., Colombai R., Gasparini R., Lo Nostro A., Tiscione E., Tomei A., Montomoli E., Comodo N.. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy. Pediatr Infect Dis J 1999 Aug; 18 (8): 677-82. IF: 1.819
  3. R. Gasparini, T. Pozzi, E. Montomoli, E. Fragapane, F. Senatore, M. Minutello and A. Podda. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur J Epidemiol. 2001;17(2):135-40. IF: 1.605
  4. Oxford JS, Manuguerra C, Kistner O, Linde A, Kunze M, Lange W, Schweiger B, Spala G, Rebelo de Andrade H, Brena PR, Beytout J, Brydak L, Caraffa de Stefano D, Hungnes O, Kyncl J, Montomoli E, Gil de Miguel A, Vranckx R, Osterhaus A. A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine. 2005, Sep 13. IF: 3.159
  5. Mike M. Pütz, Isabella Alberini, Claire M. Midgley, Ilaria Manini, Emanuele Montomoli, and Geoffrey L. Smith. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 2005 86: 2955-2960. IF: 3.410
  6. Rizzo C, Viboud C, Montomoli E, Simonsen L, Miller MA. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine. 2006 Oct 30;24(42-43):6468-75.IF: 3.159
  7. Montomoli E, Manini I. Pre-emptive vaccination against pandemic influenza virus. Vaccine. 2007 Mar 1;25(11):1921-2.IF: 3.159
  8. Valeria Alfonsi, Emanuele Montomoli, Ilaria Manini, Isabella Alberini, Chiara Gentile, Maria Cristina Rota and Marta Luisa Ciofi degli Atti. Susceptibility to varicella in childbearing age women, Central Italy: Is there a need for vaccinating this population group?Vaccine. 2007 Aug 10;25(32):6086-8. IF: 3.159
  9. Wack A, Baudner BC, Hilbert AK, Manini I, Nuti S, Tavarini S, Scheffczik H, Ugozzoli M, Singh M, Kazzaz J, Montomoli E, Del Giudice G, Rappuoli R, O'Hagan DT. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Vaccine. 2008 Jan 24;26(4):552-61. IF: 3.159
  10. Ansaldi F, Bacilieri S, Durando P, Sticchi L, Valle L, Montomoli E, Icardi G, Gasparini R, Crovari P. Cross-protection by MF59trade mark-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine. 2008 Mar 17;26(12):1525-9. IF: 3.159
  11. Francesco Pippi, Laura Bracciale, Lucia Stolzuoli, Roberta Giaccherini, Emanuele Montomoli, Chiara Gentile, Simona Filetti, Andrea De Luca, Carla Cellesi. Serological response to HBV vaccine in HIV-infected children in tanzania HIV Medicine, accepted for publication; IF: 2.082.

Papers in International Journal.

  1. Gasparini R., Pozzi T., Cuneo Crovari P., Guano G.L., Schioppa F., Romano F., Podda A., Fragapane E., Montomoli E., Crovari P.. Evaluation of Safety, Tolerability and immunogenicity of 6 licensed Influenza vaccines (formulation 1993/94). J. Prev. Med. and Hyg. 1998; 39; 23-27.
  2. Gasparini R., Pozzi T., Montomoli E., Fragapane E., Civai R., Mara E.. Vaccination against Hepatitis B - Length of protection among populations at risk. J. Prev. Med. and Hyg. 1998; 39; 37-41.
  3. Gasparini R., Pozzi T., Fragapane E., Montomoli E., Galanti I., Maurello M.T.. Descriptive study on Tubercolosis in Italy: hospitalization at Arezzo’s Hospital from 1982 until 1996. J. Prev. Med. And Hyg. 1999; 39; 80-84.
  4. Fonzi M., Montomoli E., Gasparini R., Devanna D., Fonzi L.. Morpho Structural variations of bacterial spores after treatment in steam vacum assisted autoclave. Bull. Group. Int. Rech. Sci. Stomatol. Odontol. 41 (4), 124-130, 1999.
  5. Gasparini R., Pozzi T., Montomoli E., Fragapane E.. Influenza surveillance in Siena (Italy): 1994-1997. J. Prev. Med. And Hyg. 1999; 40/1; 32-37.
  6. Gasparini R., Pozzi T., Montomoli E., Gulino M., Sansone C. M., Poliseno G., Losi E., Panatto D., Sigari G., Cuneo-Crovari P.. The Sporicidal Effects of a Biodegradable Peroxidic Disinfectant – Preliminary Results. J. Prev. Med. And Hyg. 1999; 40/2; 72-76.
  7. Gasparini R, Montomoli E., Massafra S., Gioscia C., Fragapane E., Bonnal C., Bonanni P.. Tetanus epidemiology in Europe and in Italy: a review. J. Prev. Med. And Hyg. 1999; 40/3; 77-82.
  8. Gasparini R., Pozzi T., Bonanni P., Fragapane E., Montomoli E., Lucioni C.. Valutazione dei costi di una epidemia influenzale nella popolazione lavorativa di Siena (Italia).Giornale di Farmacoeconomia. 2000; 4 (13) 3 – 9.
  9. Minutello M., Gruppioni A., Bastianoni I., Montomoli E., Gasparini R., Podda A.. Safety and immunogenicity of a subunit influenza vaccine. Clin. Microb. Inf. 6 Suppl 1 2000.
  10. R. Gasparini, A. Ciliberti, M. Gulino, E. Montomoli, P. Durando, L. Sticchi, P. Crovari. Patient information, attitude and behaviur concernine influenza vaccination at the polyclinic of Siena. J. Prev. Med. And Hyg. 2003; 44/1; 15-18.
  11. E. Montomoli, K. Cavallaro, V. Alfonsi, I. Manini, E. Battisti. A. Provvedi, C. Rizzo, R. Gasparini. A method for detection of neuraminidase antibody in serum. International Congress Series 1263 (2004) 524-527.
  12. R. Gasparini, E. Montomoli, E. Marinello, R. Guerranti, M. Sansone, S. Pilia, L. Sticchi, G. Icardi, F. Ansaldi, P. Crovari. Purification of influenza B virus Hemagglutinin by isoelectric Focusing. J. Prev. Med. And Hyg. 2004; 45/1-2; 17-20.
  13. Montomoli E., Pozzi T., Alfonsi V., Ghezzi B., Pilia S., Ravasio R., Lucioni C., Gasparini R.. Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella Provincia di Siena.Pharmacoeconomics Italian Reserch Articles 2003; Vol 5 Suppl. 1; pag. 31-38.
  14. O. Popova, D. Toneatto, R. Bugarini, B. Corbellini, E. Montomoli, C. Vagnini, G. Olivari, A.Minutello. Safety and Immunogenicity of the Thiomersal-free Chiron Influenza Vaccine Agrippal in Children and Adolescents.International Journal of Infectious Diseases; vol 8 suppl 1 march 2004 • 11th icid abstracts.
  15. R.Bugarini, B. Corbellini, O.Popova, E.Montomoli, D.Vaccina, M.A. Minutello, D.Toneatto. Thiomersal Removal: Effects on the Safety and Immunogenicity of the Chiron Influenza Vaccines AGRIPPAL S1 and FLUAD. International Journal of Infectious Diseases; vol 8 suppl 1 march 2004 • 11th icid abstracts.
  16. E. Montomoli, K. Cavallaro, V. Alfonsi, I. Manini, E. Battisti. A. Provvedi, C. Rizzo, R. Gasparini. A method for detection of neuraminidase antibody in serum. International Congress Series 1263 (2004) 524-527.
  17. Del Giudice G., Montomoli E., Manini I., Podda A.. La vaccinazione antinfluenzale e l’eterovarianza dei ceppi circolanti: uno studio comparativo. Congress Report PG 22-06-2005. Ed. Elsevier, 37-40.
  18. Bonanni P., Bechini A., Pesavento G., Boccalini S., Tiscione E., Graziani G., Santini M.G., Balocchini E., Pecori L., Peruzzi M., Mannelli F., Tomasi A., Montomoli E.. Implementation of the Plan for Elimination of Measles and Congenital Ribella Infection in Tuscany: evidence of progress towards phase II of measles control.J. Prev. Med. And Hyg. 2005; 46/3; 111-118.